相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。B16F10 Cell Membrane-Based Nanovesicles for Melanoma Therapy Are Superior to Hyaluronic Acid-Modified Nanocarriers
Yanyan Li et al.
MOLECULAR PHARMACEUTICS (2022)
Transferrin conjugated Stealth liposomes for sirolimus active targeting in breast cancer
Uttom Nandi et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2021)
Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects
Changlong Wang et al.
NATURE NANOTECHNOLOGY (2021)
A novel multi-functionalized multicellular nanodelivery system for non-small cell lung cancer photochemotherapy
Yongtai Zhang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Arsenic trioxide encapsulated liposomes prepared via copper acetate gradient loading method and its antitumor efficiency
Shaoning Wang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia
Ping Wang et al.
GENOME BIOLOGY (2020)
Affinity separation and subsequent terminal differentiation of acute myeloid leukemia cells using the human transferrin receptor (CD71) as a capture target
Veronica J. Lyons et al.
ANALYST (2019)
Arsenic trioxide: insights into its evolution to an anticancer agent
Maneka Hoonjan et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2018)
Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells
Shingo Kozono et al.
NATURE COMMUNICATIONS (2018)
Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia
Jason A. Powell et al.
BLOOD (2017)
Improved OutcomesWith Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
Uwe Platzbecker et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
Derek McCulloch et al.
ONCOTARGETS AND THERAPY (2017)
Acute Promyelocytic Leukemia A Review and Discussion of Variant Translocations
Julia Adams et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
Alan K. Burnett et al.
LANCET ONCOLOGY (2015)
Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells
Sanjay Kumar et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
F. Lo-Coco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge
S. Dadashzadeh et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells
Clement Yedjou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2010)
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Xiao-Wei Zhang et al.
SCIENCE (2010)
Lipid encapsulation of arsenic trioxide attenuates cytotoxicity and allows for controlled anticancer drug release
Haimei Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARα and PLZF-RARα oncoproteins
EM Rego et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
